Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Invivo Therapeutics Holdings Corp. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q2 2023
- Shares held
- 104.3K
- +7.08K (+7.3%) vs. Q2 2023
- Total value
- $118.5K
- −$12.5K (−9.5%) vs. Q2 2023
- New holders
- 3
- 5 more added
- Sold out
- 3
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $5.22K |
| Q4 2023 | 14 | $68.1K |
| Q3 2023 | 15 | $118.5K |
| Q2 2023 | 15 | $131.0K |
| Q1 2023 | 20 | $123.7K |
| Q4 2022 | 17 | $718.7K |
| Q3 2022 | 16 | $703.0K |
| Q2 2022 | 13 | $257.0K |
| Q1 2022 | 1 | $1.00K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Invivo Therapeutics Holdings Corp.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 34,714 | $38.9K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 28,938 | $32.4K | 0.00% | +2,692+10.3% | Added |
| Geode Capital Management, LLC | 18,677 | $22.2K | 0.00% | +7,508+67.2% | Added |
| Renaissance Technologies LLC | 13,921 | $16.0K | 0.00% | −3,345−19.4% | Reduced |
| Tower Research Capital LLC (TRC) | 7,593 | $8.50K | 0.00% | +202+2.7% | Added |
| Morgan Stanley | 270 | $303 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 102 | $114 | 0.00% | +101+10,100.0% | Added |
| Wells Fargo & Company | 23 | $26 | 0.00% | +1+4.5% | Added |
| Advisor Group Holdings, Inc. | 6 | $6 | 0.00% | −1−14.3% | Reduced |
| Colonial Trust Advisors | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Indiana Trust & Investment Management CO | 2 | $2 | 0.00% | +2 | New |
| Milestone Investment Advisors LLC | 1 | $2 | 0.00% | +1 | New |
| Sugarloaf Wealth Management, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Provenance Wealth Advisors, LLC | 1 | $1 | 0.00% | +1 | New |
| FMR LLC | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |